Lista de obras - Angel Arevalo-Martin - Dominio Público Uruguay

A CB₁/CB₂ receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin.

artículo científico publicado en 2012

A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord.

artículo científico publicado en 2013

Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis

artículo científico publicado en 2005

CB1 cannabinoid receptor enrichment in the ependymal region of the adult human spinal cord

artículo científico publicado en 2015

CB1 receptor antagonism/inverse agonism increases motor system excitability in humans.

artículo científico publicado en 2011

CB2 cannabinoid receptors promote mouse neural stem cell proliferation.

artículo científico publicado en 2007

Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis

scientific article published on 01 November 2006

Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post-natal rats through cannabinoid receptor 1 and cannabinoid receptor 2

scientific article published on 01 September 2007

Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.

artículo científico publicado en 2002

Cannabinoids to treat spinal cord injury.

artículo científico

Cells in the adult human spinal cord ependymal region do not proliferate after injury

scientific article published on 30 October 2018

Early endogenous activation of CB1 and CB2 receptors after spinal cord injury is a protective response involved in spontaneous recovery.

artículo científico publicado en 2012

Elevated Autoantibodies in Subacute Human Spinal Cord Injury Are Naturally Occurring Antibodies

artículo científico publicado en 2018

Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells.

artículo científico publicado en 2002

Interleukin-4 and interleukin-10 modulate nuclear factor kappaB activity and nitric oxide synthase-2 expression in Theiler's virus-infected brain astrocytes.

artículo científico publicado en 2002

LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10.

artículo científico publicado en 2001

Laser-Capture Microdissection for the Analysis of Rat and Human Spinal Cord Ependyma by qPCR.

artículo científico publicado en 2018

Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling

artículo científico publicado en 2013

Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.

artículo científico publicado en 2005

Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events

artículo científico publicado en 2017

Spinal cord injury induces a long-lasting upregulation of interleukin-1β in astrocytes around the central canal.

artículo científico publicado en 2014

The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation.

artículo científico publicado en 2010

The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury.

artículo científico publicado en 2010

The endocannabinoid system is modulated in response to spinal cord injury in rats

artículo científico publicado en 2008

The endocannabinoid system modulates a transient TNF pathway that induces neural stem cell proliferation

artículo científico publicado en 2008

The ependymal region of the adult human spinal cord differs from other species and shows ependymoma-like features

artículo científico publicado en 2015

The incidence and etiology of sperm DNA fragmentation in the ejaculates of males with spinal cord injuries

artículo científico publicado en 2020

Theiler's virus infection induces the expression of cyclooxygenase-2 in murine astrocytes: inhibition by the anti-inflammatory cytokines interleukin-4 and interleukin-10.

artículo científico publicado en 2002

Therapeutic action of cannabinoids in a murine model of multiple sclerosis.

artículo científico publicado en 2003

Wnts Are Expressed in the Ependymal Region of the Adult Spinal Cord

artículo científico publicado en 2016

[Theiler's virus encephalomyelitis infection as a model for multiple sclerosis: cytokines and pathogenic mechanisms]

artículo científico publicado en 2002

Lista de obras de Angel Arevalo-Martin

A CB₁/CB₂ receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin.

A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord.

Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis

CB1 cannabinoid receptor enrichment in the ependymal region of the adult human spinal cord

CB1 receptor antagonism/inverse agonism increases motor system excitability in humans.

CB2 cannabinoid receptors promote mouse neural stem cell proliferation.

Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis

Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post-natal rats through cannabinoid receptor 1 and cannabinoid receptor 2

Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.

Cannabinoids to treat spinal cord injury.

Cells in the adult human spinal cord ependymal region do not proliferate after injury

Early endogenous activation of CB1 and CB2 receptors after spinal cord injury is a protective response involved in spontaneous recovery.

Elevated Autoantibodies in Subacute Human Spinal Cord Injury Are Naturally Occurring Antibodies

Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells.

Interleukin-4 and interleukin-10 modulate nuclear factor kappaB activity and nitric oxide synthase-2 expression in Theiler's virus-infected brain astrocytes.

LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10.

Laser-Capture Microdissection for the Analysis of Rat and Human Spinal Cord Ependyma by qPCR.

Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling

Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.

Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events

Spinal cord injury induces a long-lasting upregulation of interleukin-1β in astrocytes around the central canal.

The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation.

The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury.

The endocannabinoid system is modulated in response to spinal cord injury in rats

The endocannabinoid system modulates a transient TNF pathway that induces neural stem cell proliferation

The ependymal region of the adult human spinal cord differs from other species and shows ependymoma-like features

The incidence and etiology of sperm DNA fragmentation in the ejaculates of males with spinal cord injuries

Theiler's virus infection induces the expression of cyclooxygenase-2 in murine astrocytes: inhibition by the anti-inflammatory cytokines interleukin-4 and interleukin-10.

Therapeutic action of cannabinoids in a murine model of multiple sclerosis.

Wnts Are Expressed in the Ependymal Region of the Adult Spinal Cord

[Theiler's virus encephalomyelitis infection as a model for multiple sclerosis: cytokines and pathogenic mechanisms]